ML18276A074

From kanterella
Jump to navigation Jump to search
Avanir Pharmaceuticals - Revisions to Definition of Deuterium Under 10 CFR Part 110.2
ML18276A074
Person / Time
Issue date: 09/25/2018
From: Mcdonald L
Avanir Pharmaceuticals
To: Peter Habighorst
NRC/OIP/ECNP
Owens J
References
Download: ML18276A074 (3)